STatistically Assigned Response Criteria in Solid Tumors (STARCIST)

door Bengtsson, Thomas, Sanabria-Bohorquez, Sandra M., McCarthy, Timothy J., Binns, David S., Hicks, Rodney J., de Crespigny, Alex J.
Gepubliceerd in Cancer Imaging (2015)

Phase I Dose Escalation Study of Taselisib (GDC-0032), an Oral PI3K Inhibitor, in Patients with Advanced Solid Tumors

door Juric, Dejan, Krop, Ian, Ramanathan, Ramesh K., Wilson, Timothy R., Ware, Joseph A., Sanabria Bohorquez, Sandra M., Savage, Heidi M., Sampath, Deepak, Salphati, Laurent, Lin, Ray S., Jin, Huan, Parmar, Hema, Hsu, Jerry Y., Von Hoff, Daniel D., Baselga, Jose
Gepubliceerd in Cancer Discov (2017)

A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors

door Saura, Cristina, Roda, Desamparados, Roselló, Susana, Oliveira, Mafalda, Macarulla, Teresa, Pérez-Fidalgo, José Alejandro, Morales-Barrera, Rafael, Sanchis-García, Juan Manuel, Musib, Luna, Budha, Nageshwar, Zhu, Jin, Nannini, Michelle, Chan, Wai Y., Sanabria Bohórquez, Sandra M., Meng, Raymond D., Lin, Kui, Yan, Yibing, Patel, Premal, Baselga, José, Tabernero, Josep, Cervantes, Andrés
Gepubliceerd in Cancer Discov (2016)